Savolitinib

CAS 1313725-88-0Small Molecule

Overview

Savolitinib is a potent, selective small molecule inhibitor of the c-Met receptor tyrosine kinase. It is being investigated for its potential in treating various types of cancer, especially non-small cell lung cancer.

Therapeutic areas

OncologyLung Cancer
Verified Supplier Partner

Do you supply Savolitinib? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Paclitaxel
29 suppliers
Capecitabine
25 suppliers
Anastrozole
25 suppliers
Deferasirox
24 suppliers
Palbociclib
24 suppliers
Bicalutamide
23 suppliers
Letrozole
22 suppliers
Zoledronic Acid
22 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo